Indian Institute Of Science Bengaluru receives funds Rs 425 crore to establish 800-bed multi-specialty hospital college

Published On 2022-02-15 10:56 GMT   |   Update On 2022-12-08 10:46 GMT

Bengaluru: The Indian Institute of Science (IISc) received funds worth Rs 425 crore to establish a postgraduate medical school along with an 800-bed multi-specialty hospital in its campus. 

The institute on Monday made a partnership with Susmita and Subroto Bagchi, and Radha and NS Parthasarathy, in order to construct the building which has to be named "Bagchi-Parthasarathy Hospital". The estimated cost of constructing the hospital and medical college is Rs 900 crore.

They will be trained simultaneously in the hospital as well as in the science and engineering laboratories at the IISc. Archie Medes (I) Consultants Pvt Ltd, a firm based in Ahmedabad, designed the hospital and it will be operational by the end of 2024.

Also read- IIT-G Collaborates With IISc, Bangalore For Breast Cancer Research

The Bagchi-Parthasarathy Hospital will be equipped with the latest diagnostic, treatment, and research tools. The clinical and surgical departments in the hospital will facilitate comprehensive treatment and healthcare delivery in several specialties including oncology, cardiology, neurology, endocrinology, gastroenterology, nephrology, urology, dermatology and plastic surgery, organ transplant, robotic surgery, ophthalmology, and so on.

Prof Govindan Rangarajan, Director, IISc told, "Their generous contribution will help us realize our vision of seamless coupling between clinical sciences, basic sciences, and engineering technology disciplines, all anchored within a vibrant university campus, enabling cross-disciplinary training and research opportunities for young minds. We hope that this creates a new template for institution building in India, particularly in medical research."

Also read- Infosys Foundation Signs Rs 5 Crore MoU With IISc For Infectious Diseases Research

"We are grateful for the opportunity to partner with the IISc. In a country like ours, medical research and delivery cannot be left to the government or the corporate sector alone. The time has come for more people like us to engage. With the IISc, we find a shared vision. It is an institution with depth, competence, leadership, and capacity to deliver in scale. We are greatly confident of the lasting, beneficial outcome of our donation," said Susmita Bagchi.

Radha Parthasarathy told The Indian Express, "The IISc's larger vision to integrate science, engineering, and medicine in one campus is very new to India. This is an exciting opportunity for us to collaborate. The IISc's global reputation and network will attract outstanding talent to create breakthroughs in the research and delivery of medicine. The pandemic we are living through has established the need for urgency in creating universal access and equity in medicine. We are grateful to be a part of a new journey in the history of India's most respected research institution."

Tags:    
Article Source : With Inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News